Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Qiqiang Long"'
Publikováno v:
HemaSphere, Vol 7, p e74779bf (2023)
Externí odkaz:
https://doaj.org/article/1a0cdd95e0fa45f68b98d2ab4b46d154
Autor:
Xiaoqing Liu, Yue LI, Yuemin Gong, Yawen Zhang, Xinyu Zhang, Qiqiang Long, Guangsheng He, Jianyong LI
Publikováno v:
HemaSphere, Vol 7, p e50238ad (2023)
Externí odkaz:
https://doaj.org/article/c7fda344218b4f36ab88f56fa82ce6b7
Autor:
Xiaoqing Liu, Yuemin Gong, Yue LI, Yawen Zhang, Xinyu Zhang, Qiqiang Long, Guangsheng He, Jianyong LI
Publikováno v:
HemaSphere, Vol 7, p e07304d1 (2023)
Externí odkaz:
https://doaj.org/article/04cc4a3e6cba4be1b6d9659d6c3b89d2
Autor:
Hui Yang, Yueming Gong, Yawen Zhang, Xinyu Zhang, Yue LI, Ting Zhang, Qiqiang Long, Chun Qiao, Guangsheng He, Jianyong LI
Publikováno v:
HemaSphere, Vol 7, p e766351e (2023)
Externí odkaz:
https://doaj.org/article/d3e7501dc65a40bf82a6843935804330
Autor:
Ruixin Li, Jiongtao Zhou, Zhengyuan Liu, Xi Chen, Qiqiang Long, Yan Yang, Shengyun Lin, Jinsong Jia, Guangsheng He, JianYong Li
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Addition of eltrombopag (E-PAG) to intensive immunosuppressive therapy (IST) contributes to restoring hematopoiesis in patients with severe aplastic anemia (SAA). Used at relatively low doses in the East Asian population, the efficacies of E-PAG and
Externí odkaz:
https://doaj.org/article/7cd332d9dca34046905562ee3ea590e3
Autor:
Ruixin Li, Qiqiang Long, Yan Yang, Shengyun Lin, Jinsong Jia, Donghua Zhang, Guangsheng He, Jianyong Li
Publikováno v:
Blood. 140:8650-8651
Publikováno v:
Blood. 140:2926-2927
Autor:
Guangsheng He, Qiqiang Long, Hui Yang, Jianyong Li, Ji Xu, Lei Cao, Si-Shu Zhao, Yan Wang, Rong Wang
Publikováno v:
Translational Cancer Research
Acute basophilic leukemia (ABL), as a rare form of acute myeloid leukaemia (AML) accounts for
Autor:
Lang Cheng, Qiqiang Long, Ruixin Li, Jianyong Li, Zhengyuan Liu, Xiaoqing Liu, Guangsheng He, Jiongtao Zhou
Publikováno v:
Blood. 138:1120-1120
Background Large granular lymphocyte leukemia associated pure red cell aplasia (LGLL-PRCA) accounts for a significant portion of secondary PRCA. Cyclosporine (CsA) and cyclophosphamide (CTX) are the main immunosuppressive agents used in treating LGLL
Autor:
Jinsong Jia, Qiqiang Long, Xiaoqing Liu, Lang Cheng, Jiongtao Zhou, Xi Chen, Jianyong Li, Shengyun Lin, Zhengyuan Liu, Yan Yang, Yuanyuan Jin, Ruixin Li, Guangsheng He
Publikováno v:
Blood. 138:1115-1115
Prospective trials showed the clinical efficacy of eltrombopag in refractory/relapsed aplastic anemia (AA), with up to 40% hematologic improvement [1]. Moreover, eltrombopag was combined with frontline immunosupressive therapy (IST) consisited of ant